Fractyl Health, Inc.
GUTS
$1.52
-$0.11-6.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.00K | 14.00K | 43.00K | 33.00K | 7.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.00K | 14.00K | 43.00K | 33.00K | 7.00K |
| Cost of Revenue | 0.00 | 7.00K | 24.00K | 19.00K | 2.00K |
| Gross Profit | 3.00K | 7.00K | 19.00K | 14.00K | 5.00K |
| SG&A Expenses | 4.93M | 4.80M | 6.24M | 7.13M | 2.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.21M | 23.81M | 23.03M | 21.58M | 12.99M |
| Operating Income | -25.21M | -23.79M | -22.99M | -21.54M | -12.98M |
| Income Before Tax | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M |
| EBIT | -25.21M | -23.79M | -22.99M | -21.54M | -12.98M |
| EBITDA | -24.99M | -23.59M | -22.79M | -21.49M | -12.94M |
| EPS Basic | -0.52 | -0.48 | -0.36 | -0.17 | -11.18 |
| Normalized Basic EPS | -0.31 | -0.27 | -0.22 | -0.21 | -5.40 |
| EPS Diluted | -0.52 | -0.48 | -0.36 | -0.17 | -11.18 |
| Normalized Diluted EPS | -0.31 | -0.27 | -0.22 | -0.21 | -5.40 |
| Average Basic Shares Outstanding | 48.45M | 47.97M | 47.90M | 29.74M | 2.10M |
| Average Diluted Shares Outstanding | 48.45M | 47.97M | 47.90M | 29.74M | 2.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |